GCP
RGNX icon

GSA Capital Partners’s Regenxbio RGNX Stock Holding History

GSA Capital Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
+22,607
New +$188K 0.02% 1362
2025
Q4 		– Sell
-10,348
Closed -$100K – 2018
2025
Q3 		$100K Sell
10,348
-216,234
-95% -$1.91M 0.01% 1525
2025
Q2 		$1.86M Buy
226,582
+95,253
+73% +$797K 0.13% 147
2025
Q1 		$939K Buy
131,329
+114,043
+660% +$848K 0.08% 379
2024
Q4 		$134K Buy
+17,286
New +$162K 0.01% 1488
2024
Q3 		– Sell
-151,753
Closed -$1.78M – 1946
2024
Q2 		$1.78M Buy
+151,753
New +$2.36M 0.12% 196
2023
Q4 		– Sell
-37,668
Closed -$620K – 1853
2023
Q3 		$620K Buy
+37,668
New +$683K 0.05% 665
2022
Q2 		– Sell
-10,970
Closed -$364K – 1734
2022
Q1 		$364K Buy
+10,970
New +$305K 0.05% 753
2021
Q4 		– Sell
-6,825
Closed -$286K – 1736
2021
Q3 		$286K Buy
+6,825
New +$246K 0.03% 1055
2020
Q1 		– Sell
-22,034
Closed -$903K – 1473
2019
Q4 		$903K Buy
+22,034
New +$870K 0.11% 260
2019
Q2 		– Sell
-17,966
Closed -$1.03M – 1689
2019
Q1 		$1.03M Buy
17,966
+866
+5% +$42.9K 0.1% 277
2018
Q4 		$717K Hold
17,100
– – 0.08% 369
2018
Q3 		$1.29M Sell
17,100
-788
-4% -$56.8K 0.07% 506
2018
Q2 		$1.28M Buy
+17,888
New +$854K 0.06% 580
2016
Q2 		– Sell
-15,100
Closed -$163K – 1876
2016
Q1 		$163K Buy
+15,100
New +$193K 0.01% 1532

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GSA Capital Partners's RGNX Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Regenxbio (RGNX) in Q2 2026: 22,607 shares worth $271K. The stake represents 0.02% of the portfolio and ranks #1362 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in RGNX as recently as Q3 2025.

GSA Capital Partners first reported a position in RGNX in Q1 2016 and has held it in 15 quarters since. The position peaked at $1.86M in Q2 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • GSA Capital Partners held 22,607 shares of Regenxbio worth $271K as of Q2 2026.
  • Regenxbio was a new GSA Capital Partners position in Q2 2026.
  • Regenxbio made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1362 holding.
  • GSA Capital Partners first reported a position in Regenxbio in Q1 2016 and has held it in 15 quarters since.
  • GSA Capital Partners's Regenxbio position peaked at $1.86M in Q2 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.